---
title: Managing RT Schedules of Early-Stage Breast Cancer Patients with a Genetic-Dosimetric
  Validated Model for Late Fibrosis
date: '2023-10-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37784779/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231003180922&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: We developed a multifactorial model for FG2+ based on two
  previously validated models and reported the improvement against single-factor models.
  The BEUD+PRS model is suitable for assisting clinicians in managing early-stage
  BC pts. The number of fractions or the daily dose could be reduced for RS pts. The
  integrated model resulted in a possible quantitative tool for driving the planning
  decision process. Also, it showed a better performance in the high BEUD region,
  suggesting ...'
disable_comments: true
---
CONCLUSION: We developed a multifactorial model for FG2+ based on two previously validated models and reported the improvement against single-factor models. The BEUD+PRS model is suitable for assisting clinicians in managing early-stage BC pts. The number of fractions or the daily dose could be reduced for RS pts. The integrated model resulted in a possible quantitative tool for driving the planning decision process. Also, it showed a better performance in the high BEUD region, suggesting ...